Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology — Pamela G. Galloway (1991) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology
Shared by
George Perry
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology
Article
1991
en
Authors
PG
Pamela G. Galloway
George Perry
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1989
The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease
Pamela G. Galloway
,
Catherine Bergeron
,
George Perry
Article
2006
P4–162: LRRK2 in Lewy bodies of Parkinson's disease and dementia with Lewy bodies
Mark A. Smith
,
Xiongwei Zhu
,
Asim K. Babar
,
Sandra L. Siedlak
,
Qiwei Yang
,
Genta Ito
,
Takeshi Iwatsubo
,
George Perry
,
Shu G. Chen
Article
1990
Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.
Pamela G. Galloway
,
Paul Mulvihill
,
Sandra L. Siedlak
,
Magdalena Mijares
,
Mitsuru Kawai
,
H Padget
,
R Kim
,
George Perry
Article
1999
SEQUESTRATION OF IRON BY LEWY BODIES IN PARKINSON DISEASE
Maria Rita Castellani
,
Sandra L. Siedlak
,
George Perry
,
M. A. Smith
Article
2000
Sequestration of iron by Lewy bodies in Parkinson's disease
Rudy J. Castellani
,
S. Siedlak
,
George Perry
,
Mark A. Smith
Discussion(0)
No comments yet. Be the first to comment.